Market Cap: $2.28B
NI
NeoGenomics, Inc.
NEO
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $2.28B
NeoGenomics Inc (Ticker: NEO) is experiencing notable progress in its oncology testing business, as indicated by a recent revenue guidance increase for fiscal year 2026. The company adjusts its revenu…
Earlier this week, NeoGenomics, Inc. announced a significant advancement in its oncology testing capabilities by integrating its portfolio into the Epic Aura platform. Advancing Oncology Testing throu…
NEO’s Innovation Reshapes New-Construction Real Estate Dynamics NEO (New Estate Only), a leader in global listing services for new construction real estate, receives the Global Innovation Gold Award f…
NEO Revolutionizes New-Build Real Estate with Innovation Award Win In a landmark development for the new-construction real estate sector, NEO (New Estate Only) has been honored with the Global Innovat…
Innovative Strategies Propel NEO to Global Recognition in Real Estate NEO, a pivotal player in the new-construction real estate sector, garners the Global Innovation Gold Award at The Nationals, a pre…
Neogenomics: Advancements in Cancer Diagnostics Amidst Economic Uncertainty Neogenomics, a leading provider of cancer-focused genetic testing services, demonstrates a commitment to innovation in the o…
Neogenomics: Emerging Trends in the Genetic Testing Sector Neogenomics, a leader in cancer genetics and genomics, finds itself at a critical juncture in the health sector, particularly as the demand f…
Neogenomics Expands Diagnostic Offerings to Enhance Cancer Care Neogenomics Laboratories, a prominent provider of cancer-focused genetic testing and diagnostic services, announces a strategic expansio…
Neogenomics Expands Genomic Testing Capabilities with New Partnership Neogenomics Laboratories, a prominent player in genetic testing and diagnostics, announces a strategic partnership aimed at enhanc…
Neogenomics Expands Focus on Precision Medicine with New Genomic Testing Services Neogenomics Laboratories, a leading provider of cancer-focused genetic testing services, announces a strategic expansi…
BTL’s EMSCULPT NEO: Redefining Astronaut Training for Space Missions BTL, a prominent player in the medical technology sector, achieves a remarkable milestone by integrating its flagship product, EMSC…
Revolutionizing Astronaut Training: The Role of EMSCULPT NEO in Space Preparation In a remarkable development within the realm of medical technology, BTL announces that its flagship product, EMSCULPT…
Innovative Technology Enhances Astronaut Training for Space Missions BTL, a prominent player in the medical technology sector, showcases its flagship device, EMSCULPT NEO, as a pivotal tool in prepari…
Innovative Muscle Conditioning for Space Missions: BTL's EMSCULPT NEO BTL, a leader in medical technologies, makes headlines with its EMSCULPT NEO device, which plays an integral role in the pre-fligh…
### EMSCULPT NEO: Advancing Astronaut Preparation with Innovative Technology BTL’s flagship device, EMSCULPT NEO, plays a pivotal role in preparing Hungarian research astronaut Tibor Kapu for his upco…
NeoGenomics Faces Prolonged Consolidation Period as It Enters Final Phase of Adhishthana Cycle NeoGenomics, a prominent player in the cancer diagnostics and genomic testing sector, currently finds its…
Navigating the Future: NeoGenomics and the Adhishthana Cycle NeoGenomics finds itself at a pivotal moment in its operational journey, as it enters Phase 18 of the Adhishthana Cycle, marking the final…
NeoGenomics Faces Prolonged Consolidation Phase in Market Cycle NeoGenomics, a leader in the genomics testing sector, currently finds itself in a pivotal moment as it enters Phase 18 of its Adhishthan…
NeoGenomics Triumphs in Patent Legal Battle, Bolstering Competitive Edge in Genetic Testing In a landmark decision, the District Court for the Middle District of North Carolina invalidates certain cla…
NeoGenomics Scores Legal Victory Amidst Patent Dispute with Natera In a significant development for NeoGenomics, the District Court for the Middle District of North Carolina rules to invalidate certai…
Tree of Savior: NEO Shines at Mobile Gamer Awards 2025 Neocrafts’ latest mobile MMORPG, Tree of Savior: NEO, garners significant recognition by winning the Best Trending AppGallery Game Award at the M…
### Tree of Savior: NEO Claims Best Trending AppGallery Game Award Neocrafts' Tree of Savior: NEO is recognized with the Best Trending AppGallery Game Award at the Mobile Gamer Awards 2025, a testamen…
Rejuva Fresh® Advances Aesthetic and Health Treatments with EMSHAPE NEO PLUS® Study Rejuva Fresh®, a prominent player in energy-based aesthetic technology, recently unveils a significant clinical stud…
NeoGenomics Prepares for Anticipated Quarterly Earnings Report NeoGenomics, a leading provider of cancer-focused genetic testing and services, is set to release its quarterly earnings report on July 2…
NeoGenomics Prepares for Key Earnings Report Amidst Competitive Healthcare Landscape NeoGenomics (NEO) is on the verge of releasing its quarterly earnings report on July 29, 2025, a highly anticipated…